MoneyWorks4Me

A fair growth of 19.05% in the revenue at Rs. 8525.80 millions was reported in the June 2023 quarter as compared to Rs. 7161.30 millions during year-ago period.Good  Net Profit growth of 42.73% reported above the corresponding previous quarter figure of Rs. 1012.90 millions to Rs. 1445.70 millioins.Operating Profit saw a handsome growth to 2399.60 millions from 1684.90 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 8525.80 7161.30 19.05 8525.80 7161.30 19.05 28841.60 21898.80 31.70
Other Income 51.30 5.10 905.88 51.30 5.10 905.88 86.50 386.10 -77.60
PBIDT 2399.60 1684.90 42.42 2399.60 1684.90 42.42 6733.40 5475.20 22.98
Interest 112.10 57.90 93.61 112.10 57.90 93.61 343.10 49.50 593.13
PBDT 2287.50 1627.00 40.60 2287.50 1627.00 40.60 6390.30 5425.70 17.78
Depreciation 306.50 256.90 19.31 306.50 256.90 19.31 1119.90 712.80 57.11
PBT 1981.00 1370.10 44.59 1981.00 1370.10 44.59 5270.40 4712.90 11.83
TAX 535.30 357.20 49.86 535.30 357.20 49.86 1381.50 1102.90 25.26
Deferred Tax 133.00 117.20 13.48 133.00 117.20 13.48 548.00 -122.10 -548.81
PAT 1445.70 1012.90 42.73 1445.70 1012.90 42.73 3888.90 3610.00 7.73
Equity 154.80 154.60 0.13 154.80 154.60 0.13 154.80 154.60 0.13
PBIDTM(%) 28.15 23.53 19.62 28.15 23.53 19.62 23.35 25.00 -6.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..